The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 24 , ISSUE 10 ( October, 2023 ) > List of Articles


Salivary Amylase and Mucin in Chronic Periodontitis: Pre/Post-therapy

Ebenezer Mani, Irudhaya Nirmala, P Sivasankar, Parthiban Saketharaman, Shobana Pannnerselvam, Lakshmi Priyanka

Keywords : Amylase, Chronic periodontitis, Clinical attachment level, Mucin, Oral hygiene index-simplified

Citation Information : Mani E, Nirmala I, Sivasankar P, Saketharaman P, Pannnerselvam S, Priyanka L. Salivary Amylase and Mucin in Chronic Periodontitis: Pre/Post-therapy. J Contemp Dent Pract 2023; 24 (10):813-817.

DOI: 10.5005/jp-journals-10024-3549

License: CC BY-NC 4.0

Published Online: 05-12-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Aim: The study aims to investigate the potential of salivary amylase as a reliable biochemical marker for assessing periodontal disease progression, establishing a potential correlation between salivary amylase levels and periodontal disease severity. Materials and methods: The study included 40 participants, aged 25–65, equally divided into a control and study group of 20 individuals each. Clinical parameters, such as oral hygiene index, gingival index, probing depth, and clinical attachment level were recorded. Saliva samples were collected and analyzed for amylase and mucin levels using a semi-auto analyzer and spectrophotometer, respectively. These clinical parameters and salivary biomarkers were evaluated before and after 45 days of phase I periodontal therapy. Statistical analysis, including independent samples t-test, paired samples t-test, and correlation analysis were performed to assess the treatment effectiveness and explore associations between clinical parameters and salivary biomarkers. Results: The study group with chronic generalized periodontitis showed significantly higher salivary amylase (27022.5 ± 8598.9) and mucin levels (3258 ± 724.2) and worse clinical parameters than the control group at baseline. However, after phase I periodontal therapy, the study group exhibited reduced salivary biomarkers amylase (17924.0 ± 4703.6) and mucin (1828.45 ± 314.07) and improved clinical parameters, indicating the effectiveness of the treatment in enhancing periodontal health compared with the control group. Positive correlations were found between clinical parameters and salivary amylase/mucin levels both before and after therapy (p < 0.001). Conclusion: Salivary amylase and mucin levels hold promise as valuable biomarkers for diagnosing active periodontal disease and evaluating treatment outcomes after phase I therapy. Clinical significance: Salivary biomarker comparison offers a noninvasive diagnostic tool for periodontal disease, improving early detection and personalized treatment planning. Further research is required to validate its clinical value fully.

  1. Newman MG, Takei H, Klokkevold PR, et al. Carranza's clinical periodontology. Elsevier Health Sciences; 2011.
  2. Kejriwal S, Bhandary R, Thomas B, et al. Estimation of levels of salivary mucin, amylase and total protein in gingivitis and chronic periodontitis patients. J Clin Diagn Res 2014;8(10):ZC56–ZC60. DOI: 10.7860/JCDR/2014/8239.5042.
  3. Giannobile WV, Beikler T, Kinney JS, et al. Saliva as a diagnostic tool for periodontal disease: Current state and future directions. Periodontology 2000 2009;50(1):52–64. DOI: 10.1111/j.1600-0757.2008.00288.x.
  4. Talib HJ, Ahmed MA. Assessment of salivary ά-amylase and flow rate levels and their correlation with gingivitis and severity of chronic periodontitis. J Bagh College Dent 2016;28(4):115–121. DOI: 10.12816/0033221.
  5. Paknjad M, Rezaei A. Salivary biochemical markers of periodontitis. Rom J Biochem 2013;50(2):129–146.
  6. Sanchez GA, Miozza V, Delgado A, et al. Determination of salivary levels of mucin and amylase in chronic periodontitis patients. J Periodont Res 2011;46(2):221–227. DOI: 10.1111/j.1600-0765.2010.01332.x.
  7. Wu Y, Shu R, Luo LJ, et al. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. J Periodont Res 2009;44(5):636–644. DOI: 10.1111/j.1600-0765.2008.01172.x.
  8. Almoharib HS, Almubarak A, Alrowis R, et al. Oral fluid based biomarkers in periodontal disease: Part 1. Saliva. Journal of International Oral Health 2014; 6(4):95–103. PMID: 25214743.
  9. Acquier AB, Karina A, Busch L, et al. Comparison of salivary levels of mucin and amylase and their relation with clinical parameters obtained from patients with aggressive and chronic periodontal disease. J Appl Oral Sci 2015;23(3):288–294. DOI: 10.1590/1678-775720140458.
  10. Panchbhai AS, Degwekar SS, Bhowte RR, et al. Estimation of salivary glucose, salivary amylase, salivary total protein and salivary flow rate in diabetics in India. J Oral Sci 2010;52(3):359–368. DOI: 10.2334/josnusd.52.359.
  11. Sánchez GA, Miozza VA, Delgado A, et al. Relationship between salivary leukotriene B4 levels and salivary mucin or alveolar bone resorption, in subjects with periodontal health and disease. J Periodontal Res 2013;48(6):810–814. DOI: 10.1111/jre.12070.
  12. Tobón-Arroyave SI, Jaramillo-González PE, Isaza-Guzman DM. Correlation between salivary IL-1β levels and periodontal clinical status. Arch Oral Biol 2008;53(4):346–352. DOI: 10.1016/j.archoralbio.2007.11.005.
  13. Banerjee M, Amaranath JBJ, Das N, et al. Evaluation of salivary alpha amylase as an inflammatory biomarker in chronic periodontal disease: A cross-sectional study 2023;12(4):1551–1564. DOI: 10.31838/ecb/2023.12.si4.134.
  14. Zhang CZ, Cheng X-Q, Li J-Y, et al. Saliva in the diagnosis of diseases. Int J Oral Sci 2016;8(3):133–137. DOI: 10.1038/ijos.2016.38.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.